Tweet this page
Registration as it was on 27 Oct 2022
How to read and use this data card.
Download this datacard


Lobbying Costs

900,000€ - 999,999€

Financial year: Jan 2021 - Dec 2021

Lobbyists (Full time equivalent)

2.25 Fte (7)

Lobbyists with EP accreditation


High-level Commission meetings


Lobbying Costs over the years

  • Info


    EU Transparency Register

    49654992078-52 First registered on 28 Jul 2009

    Goals / Remit

    Merck, a leading science and technology company, generated total revenues of €19,7 billion in 2021 with its divisions Healthcare, Electronics and Life Science. More than 62,000 Merck employees work in 66 countries to improve the quality of life for patients, to further the success of customers and to help meet global challenges. Merck is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent stakes, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany is holding the global rights to the Merck name and brand. The only exceptions are the United States and Canada. Here Merck operates as EMD Serono in the Biopharma business, MilliporeSigma in the Life Science business, and as EMD Performance Materials in the Performance Materials/Electronics business.

    Main EU files targeted

    European Green Deal and all relevant policies/initiatives such as:
    Chemicals Strategy for Sustainability - REACH revision, Industrial Emissions Directive, Clean Air and Water, Fit-for-55 packages, CLP regulation, Circular Economy policies

    Industrial Policy Strategy
    Digital Policies (i.e. EU Chips-Act)
    Trade policies (eg Global Gateway, customs regulations, TTC developments)
    Sustainable Finance (eg Taxonomy)

    Pharmaceutical Strategy.

    Sanctions Packages on Russia


    Head Office
    Frankfurter Strasse 250
    Darmstadt 64293
    EU Office
    Rue Belliard 40
    Brüssel 1040


  • People

    Total lobbyists declared


    Employment timeLobbyists

    Lobbyists (Full time equivalent)


    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    3 accreditations were / are live (in bold) for the selected state of 29 Nov 2022

    Name Start date End Date
    Mr Franjo CAIC 29 Oct 2022 27 Oct 2023
    Ms Liesbet DENDAS 06 Jul 2022 05 Jul 2023
    Mr Jean Paul Andre EL AHL 06 Jul 2022 05 Jul 2023
    Mr Tim MERTENS 09 Oct 2021 07 Oct 2022
    Mr Franjo CAIC 08 Oct 2021 07 Oct 2022
    Mr Jean Paul Andre EL AHL 25 Aug 2021 24 Aug 2022
    Ms Anne PAPIN DI POMPEO 27 Jul 2021 26 Jul 2022
    Mr Hugh Thomas PULLEN 20 Feb 2020 19 Feb 2021
    Ms Anne PAPIN DI POMPEO 20 Feb 2020 19 Feb 2021
    Ms Mihaela Militaru 20 Feb 2020 19 Feb 2021
    Ms Irene Maria DE CARA 20 Feb 2020 19 Feb 2021
    Ms Vanessa POTT 20 Feb 2020 19 Feb 2021
    Mr Tim MERTENS 19 Nov 2019 30 Nov 2020
    Ms Isabel VLACHOPOULOU KLINNERT 27 Mar 2019 26 Mar 2020
    Ms Anne PAPIN DI POMPEO 16 Jan 2019 15 Jan 2020
    Ms Mihaela Militaru 16 Jan 2019 15 Jan 2020
    Mr Hugh Thomas PULLEN 08 Jan 2019 31 Dec 2019
    Ms Irene Maria DE CARA 08 Jan 2019 31 Dec 2019
    Ms Vanessa POTT 04 Oct 2018 31 Oct 2019
    Mr Franjo CAIC 28 Mar 2018 27 Mar 2019
    Ms Isabel VLACHOPOULOU KLINNERT 15 Mar 2018 14 Mar 2019
    Mr Hugh Thomas PULLEN 25 Nov 2017 23 Nov 2018
    Ms Mihaela Militaru 25 Nov 2017 23 Nov 2018
    Ms Irene Maria DE CARA 25 Nov 2017 23 Nov 2018
    Ms Anne PAPIN DI POMPEO 31 Aug 2017 30 Aug 2018
    Ms Vanessa POTT 20 Jul 2017 19 Jul 2018
    Ms Sara-Andrada Dumitrana 22 Mar 2017 20 Mar 2018
    Mr Franjo CAIC 22 Mar 2017 20 Mar 2018
    Mr Hugh Thomas PULLEN 09 Nov 2016 08 Nov 2017
    Ms Irene Maria DE CARA 04 Nov 2016 02 Nov 2017
    Ms Mihaela Militaru 28 Oct 2016 27 Oct 2017
    Mr Marcel Daniels 19 Jul 2016 07 Jul 2017
    Ms Sara-Andrada Dumitrana 16 Feb 2016 04 Feb 2017
    Mr Marcel Daniels 17 Jun 2015 15 Jun 2016
    Mr Hugh Thomas PULLEN 17 Jun 2015 15 Jun 2016
    Ms Sara-Andrada Dumitrana 04 Nov 2014 30 Oct 2015
    Mrs Sara-Andrada Dumitrana 04 Nov 2014 30 Oct 2015
    Mr Hugh Thomas PULLEN 07 Jun 2014 05 Jun 2015
    Mr Marcel Daniels 06 May 2014 14 Apr 2015

    Complementary Information

    Calculation mixed: 2 persons 40%, 2 persons 10%, 1 person 25%, 2 persons 50%

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories


    Companies & groups

  • Networking


    Merck is a member of CEFIC (EU), EFPIA (EU), EBE - European Biopharmaceutical Enterprises (EU), EuropaBio, BVAC (DE with EU-office), VCI (DE) and its sub-state organisations such as LV Hessen, and DIB (Deutsche Industrievereinigung Biotechnologie), Verband forschender Arzneimittelhersteller (DE), World Economic Forum (WEF), Bitkom (DE), European Round Table of Industrialists (ERT), Cosmetics Europe, EUCCC (European Chamber of Commerce), ACATECH and various other sectoral organisations mainly at respective national/regional levels in the countries such as European General Counsel Association (UK), European Process Safety Center (UK), European Centre for Ecotoxicology and Toxicology of Chemicals (BE)

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2021 - Dec 2021

    Lobbying costs for closed financial year

    900,000€ - 999,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    eutop 200,000€ - 299,999€
    harwood levitt consulting 25,000€ - 49,999€
    nove 100,000€ - 199,999€

    Intermediaries for current year

    harwood levitt consulting

    Closed year Costs

    900,000€ - 999,999€

    Other financial info

    Any possible research/innovation fundings received and vice versa made available by Merck (e.g. in kind contributions) are not recorded.
    The estimated costs for total membership fees of Merck's trade associations are around 746.000 EUROS. Main contributions are to CEFIC, EFPIA - and VCI (10% counted for their EU activities).

  • EU Structures

    Groups (European Commission)


    Groups (European Parliament)


    Other activities

    Activities in the policy areas of Pharma and Health legislation, Energy and Climate, Environment and Chemicals legislations, Biotechnology, Taxation, Sustainable Finance, Research and Development as well as the Brexit process.

    Merck is committed to work in partnership with the European institutions to support policies and actions that facilitates patient access to treatments for unmet medical needs, especially chronic and rare diseases, as well as aspects supporting European R&D in innovative healthcare technologies.

  • Meetings


    11 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.

    • Date 08 Nov 2022 Location Brussels
      Subject Share initiatives and explore ways of collaboration and synergy
      Cabinet Cabinet of Commissioner Helena Dalli
      Portfolio Equality
      • Lesia Radelicki (Cabinet member)
    • Date 04 Apr 2022 Location virtual
      Subject Current issues such as the transformation of the European economy, and how the Chemical and Pharmaceutical industry
      Cabinet Cabinet of Commissioner Paolo Gentiloni
      Portfolio Economy
      • Alienor Margerit (Cabinet member)
    • Date 30 Nov 2021 Location Brussels
      Subject Pharma Strategy
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      • Margaritis Schinas (Vice-President)
      • Maria Luisa Llano Cardenal (Cabinet member)
    • Date 26 Oct 2021 Location Brussels
      Subject Pharmaceutical sector – trade related issues
      Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis
      Portfolio An Economy that Works for People
      • Caroline Boeshertz (Cabinet member)
      • Elina Melngaile (Cabinet member)
      • Kevin Keary (Cabinet member)
      Other Lobbyists
    • Date 03 Sep 2021 Location Brussels
      Subject FF55 and the pharmaceutical industry
      • Mauro Raffaele Petriccione (Director-General)
    • Date 12 Apr 2021 Location Brussels
      Subject Global supply chains for disposables
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      • Maurits-Jan Prinz (Cabinet member)
    • Date 02 Mar 2021 Location videoconference
      Subject Vaccine production
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 29 May 2018 Location Brussels
      Subject Preparation of the IMI 10th Anniversary
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      • Giulia Del Brenna (Cabinet member)
    • Date 14 Nov 2017 Location Strasbourg
      Subject Circular economy, priorities of Juncker Commission and AMR (Antimicrobial Resistance) Action Plan
      • Timo Pesonen (Director-General)
    • Date 23 Nov 2016 Location Brussels
      Subject EPFIA's Priorities
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      • Giulia Del Brenna (Cabinet member)
    • Date 22 Apr 2016 Location Brussels
      Subject HTA
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      • Annika Nowak (Cabinet member)
Download this datacard